Publications by authors named "Howard Yeh"

Claim this Profile
P
Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma.
Torben Plesner, Hendrik-Tobias Arkenau, Peter Gimsing, Jakub Krejcik, Charlotte Lemech, Howard Yeh

Blood· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone acetate and prednisolone for metastatic castration-resistant prostate cancer failing androgen deprivation and docetaxel-based chemotherapy: a phase II bridging study in Korean and Taiwanese patients.
Cheol Kwak, Tony Tong Lin Wu, Hyun Moo Lee, Hsi Chin Wu, Sung Joon Hong, Howard Yeh

Int J Urol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors.
David Henry, Saroj Vadhan-Raj, Vera Hirsh, Roger von Moos, Vania Hungria, Howard Yeh

Support Care Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NADPH inhibits [2Fe-2S] cluster protein transfer from diabetes drug target MitoNEET to an apo-acceptor protein.
John A Zuris, Syed S Ali, Howard Yeh, Tung A Nguyen, Rachel Nechushtai

J Biol Chem· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.
David H Henry, Luis Costa, Francois Goldwasser, Vera Hirsh, Vania Hungria, Howard Yeh

J Clin Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure.
Jean-Jacques Body, Allan Lipton, Julie Gralow, Guenther G Steger, Guozhi Gao, Howard Yeh

J Bone Miner Res· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma.
Ravi Vij, Noemi Horvath, Andrew Spencer, Kerry Taylor, Saroj Vadhan-Raj, Howard Yeh

Am J Hematol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of arsenic trioxide/bortezomib/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma.
James R Berenson, Jeffrey Matous, Regina A Swift, Russell Mapes, Blake Morrison, Howard S Yeh

Clin Cancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arsenic compounds in the treatment of multiple myeloma: a new role for a historical remedy.
James R Berenson, Howard S Yeh

Clin Lymphoma Myeloma· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.
James R Berenson, Ralph Boccia, David Siegel, Marek Bozdech, Alberto Bessudo, Howard S Yeh

Br J Haematol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment for myeloma bone disease.
Howard S Yeh, James R Berenson

Clin Cancer Res· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloma bone disease and treatment options.
Howard S Yeh, James R Berenson

Eur J Cancer· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status.
Howard S Yeh, Haiming Chen, Steven J Manyak, Regina A Swift, Richard A Campbell

Br J Haematol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purification and characterization of a cyclooxygenase-2 and angiogenesis suppressing factor produced by human fibroblasts.
Wu-Guo Deng, Michael A Saunders, Derek W Gilroy, Xue-Zhong He, Howard Yeh

FASEB J· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms of CCAAT/enhancer-binding proteins.
Ying Zhu, Michael A Saunders, Howard Yeh, Wu-guo Deng, Kenneth K Wu

J Biol Chem· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis